Delivra Health Brands Inc.
DHBUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.24 | -0.01 | 0.08 | -0.03 |
| FCF Yield | -2.72% | 7.10% | -9.89% | -6.30% |
| EV / EBITDA | 933.97 | 7.14 | -159.62 | -9.23 |
| Quality | ||||
| ROIC | -0.25% | 4.26% | -4.38% | -10.01% |
| Gross Margin | 45.96% | 53.56% | 50.15% | 46.99% |
| Cash Conversion Ratio | 2.19 | 0.80 | 1.50 | 0.41 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.16% | 10.94% | 14.48% | 14.47% |
| Free Cash Flow Growth | -148.10% | 165.64% | -89.19% | 5.93% |
| Safety | ||||
| Net Debt / EBITDA | -109.44 | -1.83 | 39.53 | 4.38 |
| Interest Coverage | -0.31 | -2.18 | -4.41 | -6.60 |
| Efficiency | ||||
| Inventory Turnover | 0.55 | 0.73 | 0.86 | 1.00 |
| Cash Conversion Cycle | 197.46 | 147.96 | 121.29 | 110.50 |